Crossmark

VS-4718 enhances apoptosis induced by low-dose carfilzomib and overcomes carfilzomib resistance in PSMB5-mutated proteasome inhibitor resistant multiple myeloma

Crossref DOI link: https://doi.org/10.1038/s41598-026-43205-4

Published Online: 2026-03-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leich-Zbat, Ellen

Heredia-Guerrero, Sofia Catalina

Evers, Marietheres

Stühmer, Thorsten

Grieb, Tina

Rauert-Wunderlich, Hilka

Bargou, Ralf C.

Rosenwald, Andreas

Chatterjee, Manik

Brünnert, Daniela
Funding

Funding for this research was provided by:

Julius-Maximilians-Universität Würzburg
License Information

Text and Data Mining valid from 2026-03-16

Version of Record valid from 2026-03-17
More Information

Article History

Received: 23 October 2025

Accepted: 2 March 2026

First Online: 16 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below